Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat

Area of Science:

• Molecular Biology
• Gene Regulation
• Protein Interactions

Background:

• CCAAT-enhancer-binding protein beta (C/EBP beta) is crucial for gene regulation.
• Previously identified EFII DNA binding complexes (EFIIa, EFIIb, EFIIc) recognize a specific C/EBP consensus site.
• The Rous sarcoma virus long terminal repeat contains the EFII enhancer sequence.

Purpose of the Study:

• To elucidate the composition of EFII DNA binding complexes.
• To characterize the different forms of C/EBP beta involved in these complexes.
• To investigate the expression and stability of C/EBP beta isoforms in different cell types.

Main Methods:

• DNA binding assays to identify components of EFII complexes.
• Dimerization experiments to determine complex composition (homodimers and heterodimers).
• Analysis of C/EBP beta protein expression and half-life in fibroblasts and lymphocytes.

Main Results:

• C/EBP beta is a major component of EFIIa, EFIIb, and EFIIc complexes.
• EFIIa is a p20 C/EBP beta homodimer; EFIIb is a p20/p35 heterodimer; EFIIc involves p20/p35 heterodimers with a 60-kDa protein.
• p20 C/EBP beta, analogous to LIP, is highly expressed in fibroblasts and lymphocytes with an extended half-life.
• Overexpression of C/EBP beta isoforms represses EFII-mediated transcription.

Conclusions:

• C/EBP beta isoforms play distinct roles in forming EFII DNA binding complexes.
• The stability and expression patterns of C/EBP beta isoforms, particularly p20, contribute to their cellular abundance.
• The repression of EFII-mediated transcription by C/EBP beta suggests the existence of other transactivators or the requirement for posttranslational modifications.